Risk factors of severe COVID-19: a review of host, viral and environmental factors

L Zsichla, V Müller - Viruses, 2023 - mdpi.com
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel

KW Ng, N Faulkner, AG Wrobel, SJ Gamblin… - Seminars in …, 2021 - Elsevier
Coronaviruses are evolutionarily successful RNA viruses, common to multiple avian,
amphibian and mammalian hosts. Despite their ubiquity and potential impact, knowledge of …

Distinct autoimmune antibody signatures between hospitalized acute COVID-19 patients, SARS-CoV-2 convalescent individuals, and unexposed pre-pandemic …

N Bhadelia, AC Belkina, A Olson, T Winters, P Urick… - MedRxiv, 2021 - medrxiv.org
Increasing evidence suggests that autoimmunity may play a role in the pathophysiology of
SARS-CoV-2 infection during both the acute and 'long COVID'phases of disease. However …

Severe acute respiratory syndrome coronavirus 2 reinfection associates with unstable housing and occurs in the presence of antibodies

DJ Bean, J Monroe, J Turcinovic… - Clinical Infectious …, 2022 - academic.oup.com
Background The factors associated with severe acute respiratory coronavirus 2 (SARS-CoV-
2) reinfection remain poorly defined. Methods We identified patients with SARS-CoV-2 …

Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence

DJ Bean, J Monroe, YM Liang, E Borberg… - Science Translational …, 2024 - science.org
Immune responses from prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) infection and COVID-19 vaccination mitigate disease severity, but they do not fully prevent …

Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19

AP Underwood, C Sølund, C Fernandez-Antunez… - …, 2021 - thelancet.com
Background Given the importance of neutralising antibodies in protection against SARS-
CoV-2 infection, it is critical to assess neutralisation persistence long-term following …

Maternal, infant, and breast milk antibody response following COVID-19 infection in early versus late gestation

EM Wachman, J Snyder-Cappione… - The Pediatric …, 2023 - journals.lww.com
Background: Coronavirus disease 2019 [severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)] infection at varying time points during the pregnancy can influence antibody …

Boosting with multiple doses of mRNA vaccine after priming with two doses of protein subunit vaccine MVC-COV1901 elicited robust humoral and cellular immune …

CH Chiu, YH Chang, CW Tao, FY Chang… - Microbiology …, 2022 - Am Soc Microbiol
Confronted with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants,
such as Delta and Omicron, with high infectivity and immune evasion capacity, vaccination …

The impact of maternal SARS‐Cov‐2 vaccination and first trimester infection on Feto‐Maternal immune responses

LJ Juttukonda, EM Wachman, J Boateng… - American Journal of …, 2022 - Wiley Online Library
Problem COVID‐19 infection during pregnancy increases maternal and fetal morbidity and
mortality. Infection in the second or third trimester leads to changes in the decidual leukocyte …

On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination

LO Fernandes-Siqueira, FAP Ferreira, BG Sousa… - Scientific Reports, 2022 - nature.com
The Covid-19 pandemic, caused by SARS-CoV-2, has resulted in over 6 million reported
deaths worldwide being one of the biggest challenges the world faces today. Here we …